Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

A real-life study on CPX-351 and the standard arm ('7 + 3') of the CPX-351 registrative trial in adults with secondary Acute Myeloid Leukemia were compared by an unanchored Matching-adjusted indirect comparison (MAIC), in order to evaluate the efficacy and toxicity of CPX-351. Results of this study are important to confirm the role of CPX-351 in significantly improving survival and remission rates compared with '7 + 3' with a good safety profile in AML patients with high-risk features, a target group traditionally with a very poor prognosis. Moreover, this pilot analysis underlines the potentiality of the statistical method to compare studies with strong differences.

Authors

Institutions

Publication Details

Journal
Annals of Hematology
Published
2025-05-01
DOI
https://doi.org/10.1007/s00277-025-06381-3
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

Anna Candoni, Valentina Mancini, Fabio Guolo, Nicola Fracchiolla et al.
Annals of Hematology
Acute Myeloid Leukemia Research
article

Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study

Anna Candoni, Valentina Mancini, Fabio Guolo, Nicola Fracchiolla, Michela Rondoni, Michele Gottardi, Monica Piedimonte, Federica Lessi, Giovanni Marsili, Lorella Melillo, Alessandro Busca, Chiara M. Cattaneo, Alfonso Piciocchi, Francesco Marchesi, Patrizia Chiusolo, Livio Pagano, Maria Ilaria Del Principe, Francesca Farina, Michela Dargenio, Luana Fianchi, Marco Picardi, Patrizia Zappasodi, Caterina Buquicchio, Paola Minetto, Rita Fazzi, Lucia Prezioso, Valentina Bonuomo, Claudia Basilico, Crescenza Pasciolla, Daniele Zama, Mario Delia, Olimpia Finizio, Francesco Restuccia, Elettra Ortu La Barbera
article en

Abstract

A real-life study on CPX-351 and the standard arm ('7 + 3') of the CPX-351 registrative trial in adults with secondary Acute Myeloid Leukemia were compared by an unanchored Matching-adjusted indirect comparison (MAIC), in order to evaluate the efficacy and toxicity of CPX-351. Results of this study are important to confirm the role of CPX-351 in significantly improving survival and remission rates compared with '7 + 3' with a good safety profile in AML patients with high-risk features, a target group traditionally with a very poor prognosis. Moreover, this pilot analysis underlines the potentiality of the statistical method to compare studies with strong differences.

Annals of HematologyVol. 104(5)
Università Cattolica del Sacro Cuore (IT), University of Foggia (IT), University of Modena and Reggio Emilia (IT), Vita-Salute San Raffaele University (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Ospedale Antonio Cardarelli (IT), Ospedale Santa Chiara (IT), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Ospedale di Rivoli (IT), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Azienda Unità Sanitaria Locale Della Romagna (IT), Istituto Oncologico Veneto (IT), Fondazione Gimema Onlus (IT), Federico II University Hospital (IT), Azienda Ospedaliera Sant'Andrea (IT), Azienda Socio Sanitaria Territoriale Lariana (IT), Policlinico Universitario di Catania (IT), Istituto Tumori Bari (IT), Ospedale di Parma (IT), Ospedale Santa Maria Goretti (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedale - Università Padova (IT), Azienda USL di Pescara (IT), Policlinico San Matteo Fondazione (IT), Ospedale Vito Fazzi (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Gruppo Italiano per il Trapianto di Midollo Osseo (IT), Instituto Nazionale Tumori Regina Elena (IT), University of Turin (IT)
Università Cattolica del Sacro Cuore
No poverty
Openalex Percentile: Top 86%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.